PKM and neoplasm: PKM2 is a key rate-limiting enzyme of glycolysis as well as an important target for tumor inhibition [47,48,49], and inhibiting the expression of PKM2 can suppress the progression of a variety of cancers, including lung [47], breast [48], and colon [49] cancers.